We are looking to implement appropriate safeguards for storage, dispensing, and administration of Myxredlin (insulin infusion). We are concerned with packaging and the risk of mix-ups with other bags which look similar--ISMP has already reported an actual error where insulin infusion run instead of cefazolin.

Can you share your practices for safeguards around following:

1. Storage--Are you storing Myxredlin in the original box or outside of the original box? What dating and storage conditions are you giving product if removing from the box (e.g. beyond use dating/protect from light packaging)?

2. Dispensing--Are you applying warning stickers to the product when dispensing? Are these warnings applied to the box or to the actual bag? When placing in the ADC (e.g. Omnicell/Pyxis) are you placing in refrigerator or in locking lid pockets/standard pockets/tower bins?

3. Administration--Any additional safeguards during administration (e.g. ADC dispense warnings)? We have a two RN mandatory signoff in our Epic-based EHR in place.

Thanks for any information you can share!

Don